By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Claremont BioSolutions today announced a distribution deal with Bioquote covering the UK and Ireland.

The deal is for Claremont's products for sample preparation, DNA isolation, and protein purification and extends the Upland, Calif.-based company's reach into Europe. The first product to be marketed will be the company's Omnilyse lysis kits and PureLyse extraction kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.